134 related articles for article (PubMed ID: 19360299)
1. Significant overexpression of Hsp110 gene during colorectal cancer progression.
Slaby O; Sobkova K; Svoboda M; Garajova I; Fabian P; Hrstka R; Nenutil R; Sachlova M; Kocakova I; Michalek J; Smerdova T; Knoflickova D; Vyzula R
Oncol Rep; 2009 May; 21(5):1235-41. PubMed ID: 19360299
[TBL] [Abstract][Full Text] [Related]
2. Differential, stage-dependent expression of Hsp70, Hsp110 and Bcl-2 in colorectal cancer.
Hwang TS; Han HS; Choi HK; Lee YJ; Kim YJ; Han MY; Park YM
J Gastroenterol Hepatol; 2003 Jun; 18(6):690-700. PubMed ID: 12753152
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling in lymph node-positive and lymph node-negative colorectal cancer.
Kwon HC; Kim SH; Roh MS; Kim JS; Lee HS; Choi HJ; Jeong JS; Kim HJ; Hwang TH
Dis Colon Rectum; 2004 Feb; 47(2):141-52. PubMed ID: 15043283
[TBL] [Abstract][Full Text] [Related]
4. Microarray analysis reveals that high mobility group A1 is involved in colorectal cancer metastasis.
Takahashi Y; Sawada G; Sato T; Kurashige J; Mima K; Matsumura T; Uchi R; Ueo H; Ishibashi M; Takano Y; Akiyoshi S; Eguchi H; Sudo T; Sugimachi K; Tanaka J; Kudo SE; Doki Y; Mori M; Mimori K
Oncol Rep; 2013 Sep; 30(3):1488-96. PubMed ID: 23835740
[TBL] [Abstract][Full Text] [Related]
5. Visinin-like protein-1 overexpression is an indicator of lymph node metastasis and poor prognosis in colorectal cancer patients.
Akagi T; Hijiya N; Inomata M; Shiraishi N; Moriyama M; Kitano S
Int J Cancer; 2012 Sep; 131(6):1307-17. PubMed ID: 22052372
[TBL] [Abstract][Full Text] [Related]
6. Expression status of wild-type HSP110 correlates with HSP110 T17 deletion size and patient prognosis in microsatellite-unstable colorectal cancer.
Kim JH; Kim KJ; Rhee YY; Oh S; Cho NY; Lee HS; Kang GH
Mod Pathol; 2014 Mar; 27(3):443-53. PubMed ID: 24030751
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiles of different clinical stages of colorectal carcinoma: toward a molecular genetic understanding of tumor progression.
Friederichs J; Rosenberg R; Mages J; Janssen KP; Maeckl C; Nekarda H; Holzmann B; Siewert JR
Int J Colorectal Dis; 2005 Sep; 20(5):391-402. PubMed ID: 15883783
[TBL] [Abstract][Full Text] [Related]
8. The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.
Takatsuno Y; Mimori K; Yamamoto K; Sato T; Niida A; Inoue H; Imoto S; Kawano S; Yamaguchi R; Toh H; Iinuma H; Ishimaru S; Ishii H; Suzuki S; Tokudome S; Watanabe M; Tanaka J; Kudo SE; Mochizuki H; Kusunoki M; Yamada K; Shimada Y; Moriya Y; Miyano S; Sugihara K; Mori M
Ann Surg Oncol; 2013 Apr; 20(4):1395-402. PubMed ID: 22976378
[TBL] [Abstract][Full Text] [Related]
9. Gab2 is a novel prognostic factor for colorectal cancer patients.
Ding C; Luo J; Yu W; Gao S; Yang L; Chen C; Feng J
Int J Clin Exp Pathol; 2015; 8(3):2779-86. PubMed ID: 26045784
[TBL] [Abstract][Full Text] [Related]
10. Down-regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer.
Wang S; Zhou J; Wang XY; Hao JM; Chen JZ; Zhang XM; Jin H; Liu L; Zhang YF; Liu J; Ding YQ; Li JM
J Pathol; 2009 Sep; 219(1):114-22. PubMed ID: 19557828
[TBL] [Abstract][Full Text] [Related]
11. Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosis.
Dorard C; de Thonel A; Collura A; Marisa L; Svrcek M; Lagrange A; Jego G; Wanherdrick K; Joly AL; Buhard O; Gobbo J; Penard-Lacronique V; Zouali H; Tubacher E; Kirzin S; Selves J; Milano G; Etienne-Grimaldi MC; Bengrine-Lefèvre L; Louvet C; Tournigand C; Lefèvre JH; Parc Y; Tiret E; Fléjou JF; Gaub MP; Garrido C; Duval A
Nat Med; 2011 Sep; 17(10):1283-9. PubMed ID: 21946539
[TBL] [Abstract][Full Text] [Related]
12. Patients with colorectal tumors with microsatellite instability and large deletions in HSP110 T17 have improved response to 5-fluorouracil–based chemotherapy.
Collura A; Lagrange A; Svrcek M; Marisa L; Buhard O; Guilloux A; Wanherdrick K; Dorard C; Taieb A; Saget A; Loh M; Soong R; Zeps N; Platell C; Mews A; Iacopetta B; De Thonel A; Seigneuric R; Marcion G; Chapusot C; Lepage C; Bouvier AM; Gaub MP; Milano G; Selves J; Senet P; Delarue P; Arzouk H; Lacoste C; Coquelle A; Bengrine-Lefèvre L; Tournigand C; Lefèvre JH; Parc Y; Biard DS; Fléjou JF; Garrido C; Duval A
Gastroenterology; 2014 Feb; 146(2):401-11.e1. PubMed ID: 24512910
[TBL] [Abstract][Full Text] [Related]
13. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
[TBL] [Abstract][Full Text] [Related]
15. Loss of the metastasis suppressor gene KiSS1 is associated with lymph node metastasis and poor prognosis in human colorectal cancer.
Okugawa Y; Inoue Y; Tanaka K; Toiyama Y; Shimura T; Okigami M; Kawamoto A; Hiro J; Saigusa S; Mohri Y; Uchida K; Kusunoki M
Oncol Rep; 2013 Sep; 30(3):1449-54. PubMed ID: 23784200
[TBL] [Abstract][Full Text] [Related]
16. FANCD2 mRNA overexpression is a bona fide indicator of lymph node metastasis in human colorectal cancer.
Ozawa H; Iwatsuki M; Mimori K; Sato T; Johansson F; Toh H; Watanabe M; Mori M
Ann Surg Oncol; 2010 Sep; 17(9):2341-8. PubMed ID: 20339950
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the signal peptide whirlin isoform 2 is related to disease progression in colorectal cancer patients.
Toiyama Y; Mizoguchi A; Kimura K; Hiro J; Tutsumi T; Inoue Y; Miki C; Kusunoki M
Int J Oncol; 2009 Oct; 35(4):709-15. PubMed ID: 19724906
[TBL] [Abstract][Full Text] [Related]
18. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
[TBL] [Abstract][Full Text] [Related]
19. Nuclear heat shock protein 110 expression is associated with poor prognosis and chemotherapy resistance in gastric cancer.
Kimura A; Ogata K; Altan B; Yokobori T; Ide M; Mochiki E; Toyomasu Y; Kogure N; Yanoma T; Suzuki M; Bai T; Oyama T; Kuwano H
Oncotarget; 2016 Apr; 7(14):18415-23. PubMed ID: 26943774
[TBL] [Abstract][Full Text] [Related]
20. Dominant high expression of wild-type HSP110 defines a poor prognostic subgroup of colorectal carcinomas with microsatellite instability: a whole-section immunohistochemical analysis.
Oh HJ; Kim JH; Lee TH; Park HE; Bae JM; Lee HS; Kang GH
APMIS; 2017 Dec; 125(12):1076-1083. PubMed ID: 28971530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
